{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:01:35Z","timestamp":1793898095905,"version":"4.8.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:p>Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease. Immune system cells have an important role in RA. Our aim was to investigate the relationship between disease activity, systemic immune-inflammation index (SII), and pan-immune-inflammation value (PIV) levels in RA patients. We planned to investigate whether these 2 measurements have an advantage over each other. About 67 patients diagnosed with RA and 49 healthy controls included in this study. RA was diagnosed based on 2010 ACR classification criteria. In this cross-sectional study, peripheral blood tests, C-reactive protein (CRP), hemogram, and erythrocyte sedimentation rate levels were noted after the physical examination of all participants. PIV was calculated with the formula: (neutrophil count\u2005\u00d7\u2005platelet count\u2005\u00d7\u2005monocyte count) \/ lymphocyte count. SII was calculated as follows: (neutrophil count\u2005\u00d7\u2005monocytes count) \/ lymphocyte count. The disease activity score 28 (DAS28) were noted in patients with RA. CRP values of active RA group were significantly higher than remission RA and control groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), control and remission RA groups were similar (<jats:italic toggle=\"yes\">P<\/jats:italic> = .86). PIV and SII are significantly higher in active RA than remission RA and control (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) higher in remission RA than control (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Receiver operating characteristic curve analysis in predicting remission compared to the control group, CRP was not significant, PIV and SII was significant and PIV has higher sensitivity and sensitivity, a PIV value of\u2005&gt;\u2005217.31 have sensitivity 75.0% and specificity 85.7%. CRP, PIV, and SII are statistically significant in predicting active RA compared to the remission RA and control group. Our findings show that PIV, and SII are easy, inexpensive and reliable markers predicting remission in RA patients. CRP was not significant compared to remission RA and control group, PIV and SII was significant and PIV has higher sensitivity and specificity than SII in the remission group in RA. Patients with high disease activity, PIV, SII, and CRP levels were effective in showing disease activity compared to RA remission group and healthy controls.<\/jats:p>","DOI":"10.1097\/md.0000000000037230","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T01:00:15Z","timestamp":1709341215000},"page":"e37230","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["The relationship between disease activity with pan-immune-inflammatory value and systemic immune-inflammation index in rheumatoid arthritis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3504-6124","authenticated-orcid":false,"given":"Pinar \u00d6zge","family":"Ba\u015faran","sequence":"first","affiliation":[{"name":"Physical Medicine and Rehabilitation Department, Erol Olcok Training and Research Hospital, Hitit University, Corum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Dogan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Internal Medicine, Hitit University, Corum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s100670050083","article-title":"Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis.","volume":"18","author":"Rashid","year":"1999","journal-title":"Clin Rheumatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis.","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis.","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells.","volume":"2","author":"Farrugia","year":"2016","journal-title":"J Clin Transl Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.cr.7290034","article-title":"Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients.","volume":"10","author":"Li","year":"2000","journal-title":"Cell Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/acr.24042","article-title":"2019 update of the American College of rheumatology recommended rheumatoid arthritis disease activity measures.","volume":"71","author":"England","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.SMJ.0000153572.22346.E9","article-title":"Laboratory testing in the rheumatic diseases: a practical review.","volume":"98","author":"Colglazier","year":"2005","journal-title":"South Med J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1007\/s10067-017-3815-2","article-title":"The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.","volume":"36","author":"Du","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e13037","DOI":"10.1111\/eci.13037","article-title":"Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis.","volume":"49","author":"Erre","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"773","DOI":"10.29271\/jcpsp.2022.06.773","article-title":"Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis.","volume":"32","author":"Dincer","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11255-022-03320-3","article-title":"Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus?","volume":"55","author":"Ozdemir","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-023-03018-6","article-title":"The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999\u20132018.","volume":"25","author":"Liu","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41416-020-0894-7","article-title":"The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.","volume":"123","author":"Fuc\u00e0","year":"2020","journal-title":"Br J Cancer"},{"key":"R16-20250504","first-page":"10","article-title":"Pan-immune-inflammation index as a biomarker for rheumatoid arthritis progression and diagnosis.","volume":"15","author":"Tutan","year":"2023","journal-title":"Cureus"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.36472\/msd.v10i6.946","article-title":"Pan-immune-inflammation value in FMF patients.","volume":"10","author":"Uluta\u015f","year":"2023","journal-title":"Med Sci Discov"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.55563\/clinexprheumatol\/m46d0v","article-title":"Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"39","author":"Lee","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.rdc.2009.10.001","article-title":"The disease activity score and the EULAR response criteria.","volume":"35","author":"Fransen","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"R20-20250504","first-page":"241","article-title":"Romatoid Artritte N\u00f6trofil\/Lenfosit ve Platelet\/Lenfosit Oranlarinin De\u011ferlendirilmesi.","volume":"43","author":"Kilic","year":"2016","journal-title":"Dicle Tip Dergisi"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s10787-022-01005-y","article-title":"Novel anti-arthritic mechanisms of trans-cinnamaldehyde against complete Freund\u2019s adjuvant-induced arthritis in mice: involvement of NF-\u043aB\/TNF-\u03b1 and IL-6\/IL-23\/IL-17 pathways in the immuno-inflammatory responses.","volume":"30","author":"El-Tanbouly","year":"2022","journal-title":"Inflammopharmacology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.2147\/IJGM.S391146","article-title":"Analysis of clinical characteristics of connective tissue disease-associated interstitial lung disease in 161 patients: a retrospective study.","volume":"15","author":"Lu","year":"2022","journal-title":"Int J Gen Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5505\/aot.2023.02703","article-title":"Prognostic role of pan immune inflammation value and systemic inflammation response index in small cell lung Cancer.","volume":"56","author":"Mehmet","year":"2023","journal-title":"Acta Oncologica Turcica"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.32708\/uutfd.1110778","article-title":"Sistemik Lupus Eritematozus Hastalarinda \u0130nflamasyon Belirteci ve Y\u00fcksek Hastalik Aktivite G\u00f6stergesi Olarak Yeni Hematolojik \u0130ndeksler.","volume":"48","author":"Ermurat","year":"2022","journal-title":"Uluda\u011f \u00dcniversitesi Tip Fak\u00fcltesi Dergisi"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00432-021-03878-y","article-title":"The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy.","volume":"148","author":"Susok","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"R27-20250504","first-page":"553","article-title":"New inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index.","volume":"47","author":"Satis","year":"2021","journal-title":"Curr Health Sci J"},{"key":"R28-20250504","first-page":"6524","article-title":"Role of systemic immune-inflammation index (SII) in assessing clinical efficacy of TNF-\u03b1 inhibitors for rheumatoid arthritis.","volume":"15","author":"Bai","year":"2023","journal-title":"Am J Transl Res"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/cancers14112675","article-title":"The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis.","volume":"14","author":"Guven","year":"2022","journal-title":"Cancers"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18663\/tjcl.985559","article-title":"The significance of pan-immune inflammation value and systemic immune inflammation Index in colorectal cancer screening.","volume":"12","author":"Kayhan","year":"2021","journal-title":"Turkish JClin Lab"},{"key":"R31-20250504","first-page":"391","article-title":"Pan-immune-inflammation value and systemic immune-inflammation index: Are they useful markers in sarcoidosis?","volume":"7","author":"Ert\u00fcrk","year":"2023","journal-title":"JOSAM"},{"key":"R32-20250504","first-page":"642","article-title":"Systemic immune inflammation index and pan-immune inflammation value as prognostic markers in patients with idiopathic low and moderate risk membranous nephropathy.","volume":"27","author":"Kazan","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:12:35Z","timestamp":1746328355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037230","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}